3/11/2016 | PP | Solazyme arranges $27.85 million placement of convertible preferreds
|
4/15/2015 | DD | Market Commentary: Energy bonds mixed despite higher oil prices; TXU off after filing plan; Solarzyme gains
|
4/14/2015 | HY | Market Commentary: Energy bonds mixed despite higher oil prices; TXU off after filing plan; Solarzyme gains
|
4/14/2015 | PP | Market Commentary: Tesla Motors in line to slightly lower; Solayzme jumps; Alcatel-Lucent up on Nokia talk
|
4/14/2015 | CV | Market Commentary: Tesla Motors in line to slightly lower; Solayzme jumps; Alcatel-Lucent up on Nokia talk
|
12/31/2014 | CV | Outlook 2015: Cheaper pricing, strong issuance eyed after convertibles pull back from 2014 levels
|
11/6/2014 | DD | Market Commentary: Molycorp bonds mauled on poor earnings; Cliffs also clobbered; hard-hit Aegerion comes back
|
11/6/2014 | HY | Market Commentary: Molycorp bonds mauled on poor earnings; Cliffs clobbered too; hard-hit Aegerion comes back
|
11/6/2014 | CV | Market Commentary: LinkedIn gains after pricing at cheap end; Aegerion regains ground; Salix shares plunge
|
10/28/2014 | PP | Market Commentary: Twitter drops outright, mixed to lower on hedge; Medicines opens up; Synergy to price
|
10/28/2014 | CV | Market Commentary: Twitter drops outright, mixed to lower on hedge; Medicines opens up; Synergy to price
|
6/20/2014 | CVLM | Solazyme to issue additional shares for exchanged 6% convertibles
|
5/22/2014 | CV | Market Commentary: Midday Commentary: New Post rises in aftermarket after upsizing; Amyris plans $75 million deal
|
4/1/2014 | CV | Solazyme greenshoe lifts 5% 5.5-year convertibles to $149.5 million
|
3/27/2014 | CV | Market Commentary: Midday Commentary: New Solazyme gains in active trade; Tesla Motors paper mixed to weaker
|
3/27/2014 | CV | New Issue: Solazyme prices upsized $130 million 5.5-year convertible notes to yield 5%, up 20%
|
3/27/2014 | CV | Market Commentary: Solazyme gains in active trade; Tesla Motors slips outright, adds on hedge; SINA sees bid
|
3/26/2014 | CV | Market Commentary: Midday Commentary: New HomeAway trades up 2.5 points on swap; Solazyme stock sags on new deal
|
3/26/2014 | CV | Market Commentary: New HomeAway trades up; Solazyme shares drop; Exelixis slumps outright, expands on hedge
|
3/26/2014 | CV | Solazyme's planned $100 million five-year convertible bonds to yield 5%-5.5%, up 20%
|
3/25/2014 | CV | Market Commentary: Planned HomeAway trades up in gray market; homebuilders a little weak; Solazyme on tap
|
3/25/2014 | CV | Solazyme to price $100 million of five-year convertible bonds
|
1/24/2013 | CV | Solazyme greenshoe fully exercised, lifts convertibles to $125 million
|
1/18/2013 | CV | New Issue: Solazyme prices upsized $115 million five-year convertible notes at 6%, up 20%
|
1/18/2013 | CV | Market Commentary: Holiday weekend results in subdued trading; Theravance, Solazyme new issues lackluster
|
1/17/2013 | CV | Market Commentary: New Pacira surges on debut; planned Theravance seen cheap; planned Solazyme lacks borrow
|
1/17/2013 | CV | Solazyme to price $100 million five-year convertibles to yield 5.5%-6%, up 20%-25%
|
12/13/2012 | CVPF | Solazyme files $30 million shelf covering stock, debt and preferrreds
|